Verano Holdings (VRNO) Cash from Investing Activities (2021 - 2026)

Verano Holdings' (VRNO) quarterly Cash from Investing Activities came in at -$14.9 million in Q1 2026, down 212.45% year-on-year from $13.3 million in Q1 2025, and down 49.56% on a QoQ basis from -$10.0 million in Q4 2025.

Verano Holdings (VRNO) Cash from Investing Activities (2021 - 2026) Analysis & Trends

Verano Holdings (VRNO) has 6 years of Cash from Investing Activities data on file, last reported at -$14.9 million in Q1 2026.

  • On a quarterly basis, Cash from Investing Activities fell 212.45% year-over-year to -$14.9 million in Q1 2026; TTM through Mar 2026 was -$42.7 million, a 66.7% increase from a year earlier, with the FY2025 full-year figure at -$32.6 million, up 75.53% from the prior year.
  • Cash from Investing Activities for Q1 2026 stood at -$14.9 million, down from -$10.0 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for VRNO reached as high as -$4.8 million in Q1 2025 and fell as low as -$92.6 million in Q3 2024.
  • Historically, Cash from Investing Activities has averaged -$24.9 million across 5 years, with a median of -$10.4 million in 2025.
  • Across the five-year window, Cash from Investing Activities surged 92.25% in 2023 and sank 830.65% in 2024, its largest moves.
  • Year by year, Cash from Investing Activities stood at -$22.6 million in 2022, then surged by 56.45% to -$9.8 million in 2023, then fell by 26.17% to -$12.4 million in 2024, then gained by 19.61% to -$10.0 million in 2025, then plunged by 49.56% to -$14.9 million in 2026.
  • Per Business Quant data, the three most recent Cash from Investing Activities figures were -$14.9 million in Q1 2026, -$10.0 million in Q4 2025, and -$7.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Haleon 89.33 Bn 87.46 Bn - -
2 Teva Pharmaceutical Industries 35.86 Bn 32.12 Bn 1.97 Bn 229.00 Mn
3 Zoetis 32.54 Bn 30.60 Bn 1.62 Bn -87.00 Mn
4 Takeda Pharmaceutical 27.63 Bn 23.57 Bn 4.39 Bn -369.95 Mn
5 United Therapeutics 23.12 Bn 20.96 Bn 648.10 Mn 743.70 Mn
6 RedHill Biopharma 21.80 Bn 21.80 Bn - -
7 Viatris 20.26 Bn 18.46 Bn 1.16 Bn 277.40 Mn
8 Neurocrine Biosciences 17.79 Bn 16.47 Bn 800.70 Mn -506.20 Mn
9 Elanco Animal Health 12.65 Bn 12.22 Bn 785.00 Mn -60.00 Mn
10 Verano Holdings 2.01 Bn 1.93 Bn 98.98 Mn -14.91 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -14.91 Mn
Mar 31, 2026 -14.91 Mn
Dec 31, 2025 -9.97 Mn
Dec 31, 2025 -9.97 Mn
Sep 30, 2025 -7.45 Mn
Sep 30, 2025 -7.45 Mn
Jun 30, 2025 -10.41 Mn
Jun 30, 2025 -10.41 Mn
Mar 31, 2025 -4.77 Mn
Mar 31, 2025 -4.77 Mn
Dec 31, 2024 -12.40 Mn
Dec 31, 2024 -12.40 Mn
Sep 30, 2024 -92.64 Mn
Sep 30, 2024 -92.64 Mn
Jun 30, 2024 -18.52 Mn
Jun 30, 2024 -18.52 Mn
Mar 31, 2024 -9.70 Mn
Mar 31, 2024 -9.70 Mn
Dec 31, 2023 -9.83 Mn
Dec 31, 2023 -9.83 Mn